Evidence map›Paper›PMID 40342448›Full record

ArticleCureus2025

Unique Presentation of Glioblastoma With Acute Onset Symptomatology and Disease Recurrence.

Angelo Federico, Alexander A Restum, Chadi Faraj

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Angelo FedericoGeneral Surgery, Corewell Health, Dearborn, USA.
Alexander A RestumMedical Education, Wayne State University School of Medicine, Detroit, USA.
Chadi FarajGeneral Surgery, Corewell Health, Dearborn, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults. This devastating disease is well known for both its poor prognosis and rapid disease progression. Associated risk factors range from increasing age to certain predisposing genetic aberrations. Despite advances in surgical, therapeutic, and immunological therapies, there has been little improvement in the overall survival rate, and GBM remains an incurable disease. Here, we report the unique case of a 54-year-old female patient who was ultimately diagnosed with GBM after presenting with a very rapid onset of symptoms and discuss both the variability in the presentation of glioblastoma and the importance of monitoring for disease recurrence.

Indexed as

cns tumorglioblastoma multiformegrade 4 astrocytomaneurologyperfusion mriradiation oncology

Identifiers

PMID40342448
PMCPMC12060197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.